SEARCH

SEARCH BY CITATION

References

  • 1
    Kleihues P,Cavenee WK. World Health Organization classification of tumors. Tumors of the nervous system. Lyon: IARC Press, 2000; 2939.
  • 2
    Perry A,Stafford SL,Scheithauer BW,Suman VJ,Lohse CM. Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol 1997; 21: 145565.
  • 3
    Lamszus K. Meningioma pathology, genetics, and biology. J Neuropathol Exp Neurol 2004; 63: 27586.
  • 4
    Seizinger BR,de la Monte S,Atkins L,Gusella JF,Martuza RL. Molecular genetic approach to human meningioma: loss of genes on chromosome 22. Proc Natl Acad Sci USA 1987; 84: 541923.
  • 5
    Dumanski JP,Carlbom E,Collins VP,Nordenskjold M. Deletion mapping of a locus on human chromosome 22 involved in the oncogenesis of meningioma. Proc Natl Acad Sci USA 1987; 84: 92759.
  • 6
    Ruttledge MH,Sarrazin J,Rangaratnam S,Phelan CM,Twist E,Merel P,Delattre O,Thomas G,Nordenskjöld M,Collins VP,Dumanski JP,Rouleau GA. Evidence for the complete inactivation of the NF2 gene in the majority of sporadic meningiomas. Nat Genet 1994; 6: 1804.
  • 7
    Wellenreuther R,Kraus JA,Lenartz D,Menon AG,Schramm J,Louis DN,Ramesh V,Gusella JF,Wiestler OD,von Deimling A. Analysis of the neurofibromatosis 2 gene reveals molecular variants of meningioma. Am J Pathol 1995; 146: 82732.
  • 8
    Weber RG,Boström J,Wolter M,Baudis M,Collins VP,Reifenberger G,Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997; 94: 1471924.
  • 9
    Rempel SA,Schwechheimer K,Davis RL,Cavenee WK,Rosenblum ML. Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 1993; 53: 238692.
  • 10
    Lindblom A,Ruttledge M,Collins VP,Nordenskjöld M,Dumanski JP. Chromosomal deletions in anaplastic meningiomas suggest multiple regions outside chromosome 22 as important in tumor progression. Int J Cancer 1994; 56: 3547.
  • 11
    Simon M,von Deimling A,Larson JJ,Wellenreuther R,Kaskel P,Waha A,Warnick RE,Tew JM,Menon AG. Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 1995; 55: 4696701.
  • 12
    Sulman EP,Dumanski JP,White PS,Zhao H,Maris JM,Mathiesen T,Bruder C,Cnaan A,Brodeur GM. Identification of a consistent region of allelic loss on 1p32 in meningiomas: correlation with increased morbidity. Cancer Res 1998; 58: 322630.
  • 13
    Ishino S,Hashimoto N,Fushiki S,Date K,Mori T,Fujimoto M,Nakagawa Y,Ueda S,Abe T,Inazawa J. Loss of material from chromosome arm 1p during malignant progression of meningioma revealed by fluorescent in situ hybridization. Cancer 1998; 83: 3606.
  • 14
    Bello MJ,de Campos JM,Vaguero J,Kusak ME,Sarasa JL,Rev JA. High-resolution analysis of chromosome arm 1p alterations in meningioma. Cancer Genet Cytogenet 2000; 120: 306.
  • 15
    Sulman EP,White PS,Brodeur GM. Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34. Oncogene 2004; 23: 101420.
  • 16
    Buckley PG,Jarbo C,Menzel U,Mathiesen T,Scott C,Gregory SG,Langford CF,Dumanski JP. Comprehensive DNA copy number profiling of meningioma using a chromosome 1 tiling path microarray identifies novel candidate tumor suppressor loci. Cancer Res 2005; 65: 265361.
  • 17
    Hata N,Yoshimoto K,Yokoyama N,Mizoguchi M,Shono T,Guan Y,Tahira T,Kukita Y,Higasa K,Nagata S,Iwaki T,Sasaki T, et al. Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis. Clin Chem 2006; 52: 3708.
  • 18
    Rozen S,Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132: 36586.
  • 19
    Inazuka M,Wenz HM,Sakabe M,Tahira T,Hayashi K. A streamlined mutation detection system: multicolor post-PCR fluorescence labeling and single-strand conformational polymorphism analysis by capillary electrophoresis. Genome Res 1997; 7: 1094103.
  • 20
    Kukita Y,Higasa K,Baba S,Nakamura M,Manago S,Suzuki A,Tahira T,Hayashi K. A single-strand conformation polymorphism method for the large-scale analysis of mutations/polymorphisms using capillary array electrophoresis. Electrophoresis 2002; 23: 225966.
  • 21
    Baba S,Kukita Y,Higasa K,Tahira T,Hayashi K. Single-stranded conformational polymorphism analysis using automated capillary array electrophoresis apparatuses. Biotechniques 2003; 34: 74650.
  • 22
    Higasa K,Kukita Y,Baba S,Hayashi K. Software for machine-independent quantitative interpretation of SSCP in capillary array electrophoresis (QUISCA). Biotechniques 2002; 33: 13428.
  • 23
    Yoshimoto K,Iwaki T,Inamura T,Fukui M,Tahira T,Hayashi K. Multiplexed analysis of post-PCR fluorescence-labeled microsatellite alleles and statistical evaluation of their imbalance in brain tumors. Jpn J Cancer Res 2002; 93: 28490.
  • 24
    Murakami M,Hashimoto N,Takahashi Y,Hosokawa Y,Inazawa J,Mineura K. A consistent region of deletion on 1p36 in meningiomas: identification and relation to malignant progression. Cancer Genet Cytogenet 2003; 140: 99106.
  • 25
    Boehm D,Herold S,Kuechler A,Liehr T,Laccone F. Rapid detection of subtelomeric deletion/duplication by novel real-time quantitative PCR using SYBR-green dye. Hum Mutat 2004; 23: 36878.
  • 26
    Arslantas A,Artan S,Oner U,Durmaz R,Muslumanoglu H,Atasoy MA,Basaran N,Tel E. Comparative genomic hybridization analysis of genomic alterations in benign, atypical and anaplastic meningiomas. Acta Neurol Belg 2002; 102: 5362.
  • 27
    Muller P,Henn W,Niedermayer I,Ketter R,Feiden W,Steudel WI,Zang KD,Steilen-Gimbel H. Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res 1999; 5: 356977.
  • 28
    Nigro JM,Takahashi MA,Ginzinger DG,Law M,Passe S,Jenkins RB,Aldape K. Detection of 1p and 19q loss in oligodendroglioma by quantitative microsatellite analysis, a real-time quantitative polymerase chain reaction assay. Am J Pathol 2001; 158: 125362.
  • 29
    Tai AL,Mak W,Ng PK,Chua DT,Ng MY,Fu L,Chu KK,Fang Y,Qiang SY,Chen M,Zhang M,Sham PC, et al. High-throughput loss-of-heterozygosity study of chromosome 3p in lung cancer using single-nucleotide polymorphism markers. Cancer Res 2006; 66: 41338.
  • 30
    Huang J,Wei W,Zhang J,Liu G,Bignell GR,Stratton MR,Futreal PA,Wooster R,Jones KW,Shapero MH. Whole genome DNA copy number changes identified by high density oligonucleotide arrays. Hum Genomics 2004; 1: 28799.
  • 31
    Wong KK,Tsang YT,Shen J,Cheng RS,Chang YM,Man TK,Lau CC Allelic imbalance analysis by high-density single-nucleotide polymorphic allele (SNP) array with whole genome amplified DNA. Nucleic Acids Res 2004; 32: e69.
  • 32
    Beroukhim R,Lin M,Park Y,Hao K,Zhao X,Garraway LA,Fox EA,Hochberg EP,Mellinghoff IK,Hofer MD,Descazeaud A,Rubin MA, et al. Inferring loss-of-heterozygosity from unpaired tumors using high-density oligonucleotide SNP arrays. PLoS Comput Biol 2006; 2: e41.
  • 33
    Peiffer DA,Le JM,Steemers FJ,Chang W,Jenniges T,Garcia F,Haden K,Li J,Shaw CA,Belmont J,Cheung SW,Shen RM, et al. High-resolution genomic profiling of chromosomal aberrations using Infinium whole-genome genotyping. Genome Res 2006; 16: 113648.
  • 34
    Bello MJ,de Campos JM,Kusak ME,Vaquero J,Sarasa JL,Pestana A,Rey JA. Allelic loss at 1p is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 1994; 9: 2968.
  • 35
    Bostrom J,Muhlbauer A,Reifenberger G. Deletion mapping of the short arm of chromosome 1 identifies a common region of deletion distal to D1S496 in human meningiomas. Acta. Neuropathol 1997; 94: 47985.
  • 36
    Leuraud P,Marie Y,Robin E,Huguet S,He J,Mokhtari K,Cornu P,Hoang-Xuan K,Sanson M. Frequent loss of 1p32 region but no mutation of the p18 tumor suppressor gene in meningiomas. J Neurooncol 2000; 50: 20713.
  • 37
    Lomas J,Bello MJ,Arjona D,Gonzalez-Gomez P,Alonso ME,de Campos JM,Vaquero J,Ruiz-Barnes P,Sarasa JL,Casartelli C,Rey JA. Analysis of p73 gene in meningiomas with deletion at 1p. Cancer Genet Cytogenet 2001; 129: 8891.
  • 38
    Bostrom J,Meyer-Puttlitz B,Wolter M,Blaschke B,Weber RG,Lichter P,Ichimura K,Collins VP,Reifenberger G. Alterations of the tumor suppressor genes CDKN2A (p16(INK4a)), p14(ARF). CDKN2B (p15(INK4b)), and CDKN2C (p15(INK4c)) in atypical and anaplastic meningiomas. Am J Pathol 2001; 159: 6619.
  • 39
    Mendiola M,Bello MJ,Alonso J,Leone PE,Vaquero J,Sarasa JL,Kusak ME,De Campos JM,Pestana A,Ray JA. Search for mutations of the hRAD54 gene in sporadic meningiomas with deletion at 1p32. Mol Carcinog 1999; 24: 3004.
  • 40
    Niedermayer I,Feiden W,Henn W,Steilen-Gimbel H,Steudel WI,Zang KD. Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique in indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 1997; 56: 87986.
  • 41
    Li QL,Ito K,Sakakura C,Fukamachi H,Inoue K,Chi XZ,Lee KY,Nomura S,Lee CW,Han SB,Kim HM,Kim WJ, et al. Causal relationship between the loss of RUNX3 expression and gastric cancer. Cell 2002; 109: 11324.
  • 42
    Ku JL,Kang SB,Shin YK,Kang HC,Hong SH,Kim IJ,Shin JH,Han IO,Park JG. Promoter hypermethylation downregulates RUNX3 gene expression in colorectal cancer cell lines. Oncogene 2004; 23: 673642.
  • 43
    Lau QC,Raja E,Salto-Tellez M,Liu Q,Ito K,Inoue M,Putti TC,Loh M,Ko TK,Huang C,Bhalla KN,Zhu T, et al. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res 2006; 66: 651220.
  • 44
    Sato K,Tomizawa Y,Ijima H,Saito R,Ishizuka T,Nakajima T,Mori M. Epigenetic inactivation of the RUNX3 gene in lung cancer. Oncol Rep 2006; 15: 12935.
  • 45
    Kim BT,Kitagawa H,Tamura J,Saito T,Kusche-Gullberg M,Lindahl U,Sugahara K. Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α 1,4-N-acetylglucosaminyltransferases that likely are involved in heparin sulfate/heparin biosynthesis. Proc Natl Acad Sci USA 2001; 98: 717681.